ATE285412T1 - Thienopyrimidine als phosphodiesterase hemmer - Google Patents

Thienopyrimidine als phosphodiesterase hemmer

Info

Publication number
ATE285412T1
ATE285412T1 AT00936871T AT00936871T ATE285412T1 AT E285412 T1 ATE285412 T1 AT E285412T1 AT 00936871 T AT00936871 T AT 00936871T AT 00936871 T AT00936871 T AT 00936871T AT E285412 T1 ATE285412 T1 AT E285412T1
Authority
AT
Austria
Prior art keywords
thienopyrimidine
phosphodiesterase inhibitor
phosphodiesterase
inhibitor
Prior art date
Application number
AT00936871T
Other languages
English (en)
Inventor
Rochus Jonas
Pierre Schelling
Franz-Werner Kluxen
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE285412T1 publication Critical patent/ATE285412T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00936871T 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer ATE285412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19928146A DE19928146A1 (de) 1999-06-19 1999-06-19 Thienopyrimidine
PCT/EP2000/005278 WO2000078767A1 (de) 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer

Publications (1)

Publication Number Publication Date
ATE285412T1 true ATE285412T1 (de) 2005-01-15

Family

ID=7911858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936871T ATE285412T1 (de) 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer

Country Status (24)

Country Link
US (1) US6787548B1 (de)
EP (1) EP1189907B1 (de)
JP (1) JP2003502429A (de)
KR (1) KR20020010719A (de)
CN (1) CN1144806C (de)
AR (1) AR024380A1 (de)
AT (1) ATE285412T1 (de)
AU (1) AU767273B2 (de)
BR (1) BR0011778A (de)
CA (1) CA2375278A1 (de)
CZ (1) CZ293901B6 (de)
DE (2) DE19928146A1 (de)
ES (1) ES2234613T3 (de)
HK (1) HK1047434B (de)
HU (1) HUP0201730A3 (de)
MX (1) MXPA01013228A (de)
NO (1) NO20016201D0 (de)
PL (1) PL351822A1 (de)
PT (1) PT1189907E (de)
RU (1) RU2238274C2 (de)
SK (1) SK18222001A3 (de)
UA (1) UA72256C2 (de)
WO (1) WO2000078767A1 (de)
ZA (1) ZA200200440B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
RU2409581C2 (ru) * 2004-12-13 2011-01-20 Зольвай Фармасьютиклз Гмбх НОВЫЕ ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ТИОФЕНПИРИМИДИНОНА В КАЧЕСТВЕ ИНГИБИТОРОВ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド 神経発生のgaba受容体媒介調節
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
MXPA01013228A (es) 2002-07-02
HUP0201730A2 (en) 2002-09-28
SK18222001A3 (sk) 2002-06-04
NO20016201L (no) 2001-12-18
JP2003502429A (ja) 2003-01-21
EP1189907A1 (de) 2002-03-27
CN1144806C (zh) 2004-04-07
KR20020010719A (ko) 2002-02-04
AU767273B2 (en) 2003-11-06
WO2000078767A1 (de) 2000-12-28
CN1355805A (zh) 2002-06-26
BR0011778A (pt) 2002-04-23
RU2238274C2 (ru) 2004-10-20
EP1189907B1 (de) 2004-12-22
ZA200200440B (en) 2003-06-25
NO20016201D0 (no) 2001-12-18
UA72256C2 (uk) 2005-02-15
ES2234613T3 (es) 2005-07-01
HK1047434A1 (en) 2003-02-21
US6787548B1 (en) 2004-09-07
CZ293901B6 (cs) 2004-08-18
AR024380A1 (es) 2002-10-02
CZ20014422A3 (cs) 2002-03-13
PL351822A1 (en) 2003-06-16
HK1047434B (zh) 2005-01-28
HUP0201730A3 (en) 2004-12-28
AU5220400A (en) 2001-01-09
CA2375278A1 (en) 2000-12-28
DE19928146A1 (de) 2000-12-21
PT1189907E (pt) 2005-05-31
DE50009042D1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
DE60042620D1 (de) Pyrrolotriazine als Kinase Hemmer.
ATE285412T1 (de) Thienopyrimidine als phosphodiesterase hemmer
ATE333446T1 (de) Pyrimidin-4-onderivat als ldl-pla2 inhibitor
ATE256127T1 (de) Betacarbolinderivate als phosphodiesterase- inhibitoren
PT1049695E (pt) Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
DE60134094D1 (de) C7-taxanester als antitumormittel
ATE278690T1 (de) Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
CY2015035I1 (el) Ενωσεις πυριμιδινης
NO20025977L (no) Imidazopyridin - og imidazopyrimidin antivirale forbindelser
DE60123294D1 (de) Diazepan Derivate als Faktor X Inhibitor
NO20024127D0 (no) Pyrimidin-forbindelser
DE50013473D1 (de) Pyrrolderivate als phosphodiesterase vii-hemmer
DE50001663D1 (de) Imidazopyridinderivate als phosphodiesterase vii-hemmer
DE60036919D1 (de) Fahrzeug als gehhilfe
DE59905215D1 (de) Bördelvorrichtung
DE50003036D1 (de) Imidazolverbindungen als phosphodiesterase vii-hemmer
NO20016189L (no) SRSV deteksjonssett
DE60142478D1 (de) Spannwerkzeughalter
DE50010885D1 (de) Isoxazolderivate als phosphodiesterase vii-hemmer
ATE277912T1 (de) Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer
DE60027180D1 (de) Korrelator
DE50003309D1 (de) Imidazolderivate als phosphodiesterase vii-hemmer
AR027952A1 (es) Compuesto ceclico
DE50110971D1 (de) Werkzeughalter

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee